# A Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic Mesothelioma

> **NCT04056026** · EARLY_PHASE1 · COMPLETED · sponsor: **ProgenaBiome** · enrollment: 1 (actual)

## Conditions studied

- Mesothelioma

## Interventions

- **BIOLOGICAL:** Fecal Microbiota Transplant

## Key facts

- **NCT ID:** NCT04056026
- **Lead sponsor:** ProgenaBiome
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-18
- **Primary completion:** 2018-12-18
- **Final completion:** 2018-12-18
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2019-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04056026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04056026, "A Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic Mesothelioma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04056026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*